Quality of Kyeongbo's Bacampicillin bulk approved in Europe.

Published: 2003-10-16 06:58:00

Updated: 2003-10-16 06:58:00

Kyeongbo Pharmaceutical company (President: Kim Young-eun) announced that the bulk of Bacampicillin Hcl, a semi-synthetic penicillin, had obtained its Certificate of Suitability (COS) in Europe, a European drug quality approval, for the first time in Korea.

The COS is one of the most authori...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK